NovaDel Pharma Inc. (the “Company”) (OTCBB: NVDL) is pleased to announce that its common stock will begin trading on the Over-the-Counter Bulletin Board (“OTCBB”) on December...
NovaDel Pharma Inc. (NYSE AMEX: NVD), today announced that it received an Issue Notification from the United States Patent and Trademark Office (USPTO) for a new U.S. Patent...
On December 2, 2009, NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD) notified NYSE Amex LLC (“Exchange”) of its intent of voluntarily delist its common stock from the...
NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported...
NovaDel Pharma Inc. (NYSE AMEX: NVD) today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned...
NovaDel Pharma Inc. (NYSE AMEX: NVD), today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S...
NovaDel Pharma Inc., (NYSE AMEX: NVD) has entered into a licensing agreement with privately-held Mist Acquisition, LLC to manufacture and commercialize the NitroMist® lingual...
NovaDel Pharma Inc. (NYSE AMEX: NVD) held its 2009 Annual Meeting of Stockholders on October 15, 2009. Mr. Mark Baric, Mr. Thomas Bonney, Mr. Steven Ratoff and Dr. Charles...
NovaDel Pharma Inc. (NYSE AMEX: NVD) announced that an article titled “Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine” was published...
On August 17, 2009, NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD) received a milestone payment of approximately $150,000 from Velcera, Inc. (“Velcera”) relating to its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.